Mood Stabilizers News and Research

RSS

Study suggests treating anxiety and depression significantly reduces ER visits and rehospitalizations among heart disease patients

A new study looks at this area in order to provide evidence for key recommendations in the treatment of such patients.

22 Mar 2024

INTEGRA supports the next generation of synthetic biologists

INTEGRA Biosciences awarded 3 PIPETBOY acu 2 serological pipette controllers to the 2023 iGEM Competition team at Technische Universität Braunschweig (TU_BS) to aid their pioneering research into lithium therapy toxicity testing.

From INTEGRA Biosciences 8 Mar 2024

Could CaMKK2 enzyme be the key to treating bipolar disorder?

Researchers explore the role of the CaMKK2 signaling pathway in bipolar disorder, suggesting it as a new treatment target. By targeting this enzyme, scientists aim to develop more effective therapies for bipolar symptoms and metabolic dysfunction.

24 Sep 2023

Antidepressants may help prevent bipolar depression relapse

Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the University of British Columbia.

2 Aug 2023

Genes underlying cigarette smoking linked to the perception of pain and response to food

Have you ever wondered why one person can smoke cigarettes for a year and easily quit, while another person will become addicted for life? Why can't some people help themselves from abusing alcohol and others can take it or leave it?

20 Jul 2022

Study shows link between psychotropic medication use and post-Covid dementia

Recent studies have highlighted the connection between coronavirus disease 2019 (COVID-19) infection and the development of dementia.

23 Mar 2022

Research clarifies neuron-specific DNA methylation changes and characteristics in bipolar disorder

A research collaboration based in Kumamoto University, Japan has revealed the DNA methylation status of gene transcriptional regulatory regions in the frontal lobes of patients with bipolar disorder (BD).

9 Jun 2021

Untreated mental health disorders can affect women and their children during and after pregnancy

Untreated mental health disorders can be a serious problem for women and their children during pregnancy and after giving birth, during the postpartum period.

5 May 2021

Scientists receive two-year grant to develop tool for treating mood disorders

A team of Georgia State scientists has received a two-year, $875,110 grant from the National Institute of Mental Health to further develop a tool to help psychiatrists treat mood disorders.

1 Oct 2020

An overview of withdrawal syndromes following discontinuation of psychotropic drugs

The current issue of Psychotherapy and Psychosomatics reports an article that analyzes the data that are available on what may happen when psychotropic drugs are discontinued.

24 Sep 2020

Tips to help smokers and vapers quit smoking

As the American Cancer Society prepares to help smokers kick the habit during tomorrow's Great American Smokeout, Cedars-Sinai is offering tips for quitting smoking, whether you are hooked on tobacco or vaping.

20 Nov 2019

Suicidal patients with prescribed access to psychotropic drugs should be closely monitored

As prescriptions for psychotropic drugs increase, researchers at the University of Colorado Anschutz Medical Campus have found that prescribed access to anti-anxiety and anti-psychotic medications may make it easier for some patients to use the drugs in attempted suicides.

13 Nov 2018

New AI algorithm helps predict medication response in patients with complex mood disorder

Mood disorders like major depressive disorder and bipolar disorder are often complex and hard to diagnose, especially among youth when the illness is just evolving.

9 Aug 2018

Low levels of allopregnanolone hormone may predict risk of postpartum depression

In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.

14 Mar 2017

Study reveals self-harm is leading cause of pregnancy-related deaths in Colorado

Self-harm was the leading cause of pregnancy-associated deaths in Colorado from 2004 to 2014, ahead of car crashes, medical conditions and homicide, according to researchers at the University of Colorado Anschutz Medical Campus.

9 Dec 2016

Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

A drug prescribed to many patients with schizophrenia or bipolar disorder may decrease negative symptoms for people with a certain variant of the COMT gene, suggests a new study from researchers at Columbia University Medical Center.

14 Sep 2016

Depressive symptoms may affect fertility of women

Women with severe depressive symptoms have a decreased chance of becoming pregnant, while the use of psychotropic medications does not appear to harm fertility, a study by researchers from the Boston University Schools of Public Health and Medicine shows.

25 May 2016

Understanding the pathophysiology of bipolar disorder

Advances in magnetic resonance imaging (MRI) acquisition and analyses over the last two decades have enabled the identification of neuroanatomical abnormalities in a range of mental disorders, however one question which has consistently surfaced is the extent to which the medications used to treat such disorders may accentuate or ameliorate these abnormalities.

17 Feb 2016

Mylan releases generic version of Invega in the U.S.

Mylan N.V. today announced the U.S. launch of Paliperidone Extended-Release Tablets 1.5 mg, 3 mg, 6 mg and 9 mg, the generic version of Janssen's Invega.

28 Sep 2015

Antidepressants can increase depression, mood cycling in rapid-cycling bipolar disorder patients

In patients with rapid-cycling bipolar disorder, antidepressants can increase incidents of depression and mood cycling. Rif S. El-Mallakh, M.D., director of the Mood Disorders Clinical and Research Program at the University of Louisville, along with Nassir Ghaemi, M.D., of Tufts University and other researchers, conducted the first randomized clinical trial that analyzes how modern antidepressants affect patients with rapid-cycling (RC) bipolar disorder (BD).

15 Sep 2015